Source: MassDevice

ThermiAesthetics: FDA clears Thermi in "vaginal rejuvenation" product inquiry

Temp-controlled radiofrequency tech developer Thermi said this week that the FDA granted it a notice of completion following an inquiry on products used in "vaginal rejuvenation" procedures. Irving, Texas-based Thermi received a notice from the FDA on July 24 regarding specific claims about the company's ThermiVa device. The ThermiVa is a non-ablative RF device cleared [...]The post FDA clears Thermi in "vaginal rejuvenation" product inquiry appeared first on MassDevice.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Vladimir Paul-Blanc's photo - President of Thermi

President

Vladimir Paul-Blanc

CEO Approval Rating

90/100

Read more